Bioventus Inc. (BVS) Social Stream



Bioventus Inc. (BVS): $4.35

0.18 (+4.32%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

BIOVENTUS INC (BVS) Price Targets From Analysts

Use the tables below to see what analysts covering BIOVENTUS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-03-08 1 $23 $23 $23 $3.94 483.76%
2021-11-10 3 $25 $23 $24 $3.94 509.14%
2022-01-25 2 $25 $20 $22.5 $3.94 471.07%
2022-05-11 3 $30 $18 $23 $3.94 483.76%
2022-07-14 3 $30 $11 $20.666 $3.94 424.52%
2022-08-12 4 $30 $12 $18 $3.94 356.85%
2022-09-07 4 $30 $12 $16.75 $3.94 325.13%
2022-10-11 4 $30 $11 $16.5 $3.94 318.78%
2022-11-09 4 $13 $5 $8.5 $3.94 115.74%
2022-11-30 4 $10 $2.5 $5.875 $3.94 49.11%
2023-04-03 3 $6 $5 $5.333 $3.94 35.36%
2023-08-10 2 $6 $6 $6 $3.94 52.28%

The Trend in the Analyst Price Target


Over the past 13 months, BVS's average price target has gone down $14.67.

BVS reports an average of 204.51% for its upside potential over the past 36 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-11-30 4 10 2.5 5.875 1.95 201.28%
2023-04-03 3 6 5.0 5.500 1.13 386.73%
2023-04-03 3 6 5.0 5.333 1.13 371.95%
2023-08-10 2 6 6.0 6.000 4.57 31.29%
2023-08-10 3 6 6.0 6.000 4.57 31.29%

BVS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3 1 0 1 1 1 3

The Trend in the Broker Recommendations


BVS's average broker recommendation rating worsened by 2 over the prior 13 months.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • BIOVENTUS INC's number of analysts covering the stock is greater than 193.98% of all US stocks.
  • In the context of all US stocks, BIOVENTUS INC's variance in analysts' estimates is lower than -933.91% of them.
  • In terms of how BIOVENTUS INC fares relative to Medical Equipment stocks, note that its average analyst price target is greater than 423.61% of that group.
  • In the context of Medical Equipment stocks, BIOVENTUS INC's upside potential (average analyst target price relative to current price) is greater than 1454.69% of them.

In the Medical Equipment industry, NPCE, TMCI, and CVRX are the three stocks most similar to BIOVENTUS INC regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding BVS using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!